BioClinical Solutions will be at Advanced Therapies and Medidata NEXT in London!
Our Core Team of Experts
Our Leadership Team
Our leadership team, led by Founder & CEO Kimberly Finn and Co-Founder & CSO Gaurang Majmudar, brings together decades of expertise in biotech innovation, clinical operations, and strategic development. Supported by Amy Gutierrez and Amy Pinette together with a network of strategic consultants, Bioclinical Solutions is committed to driving innovation and delivering impactful healthcare solutions.
Kimberly Finn
Kimberly Finn, Founder and CEO is a seasoned executive with 30+ years expertise as a pharmaceutical / CRO professional focused in R&D operations and building of innovative service lines within the traditional and decentralized clinical trial arena resulting in increased patient centricity and expedited delivery of clinical programs. Kimberly has demonstrated successful experience in corporate strategy as well as operational expertise which has resulted in the successful organic development of a global Home Health Care service line with a go live within 18 months and ultimately achieving market leadership within 2 years of service activation. Kimberly has numerous successful NDAs behind her as well as a strong experience in efficient clinical program designs and operations. Kimberly is based in Chicago, IL
Gaurang Majmudar
Gaurang Majmudar, Founding Partner and CSO is a pharmaceutical professional with a 30+ years track record of delivering excellence, both strategically and commercially. Executive experience across the pharmaceutical development lifecycle, in roles that uniquely span from Clinical Operations to Commercialization. Gaurang has passionately focused on patient centricity and has successfully built HHC operations in Europe and APAC resulting in the launch of numerous first in country patient centric Decentralized Clinical Studies & Patient Access solutions for Specialty, and Rare Disease medicines. Gaurang is based in the London, UK
Amy Gutierrez
Amy Gutierrez, Senior Consultant is a Sr. Clinical Research professional with 25+ years of expertise in the CRO, Pharmaceutical, and Biotech environments with extensive experience within Project Management and Study Start-Up. Expertise extends to site start-up, including knowledge of site staff experience/requirements for study selection, regulatory requirements to begin a trial, completion of documentation for start-up, as well working with vendors to ensure that site is ready for site activation. Amy's Project Management, focus on site ID, working with sites to ensure rapid start-up for study start and during the clinical trial maintaining enrollment goals, working with vendors for start-up and throughout the clinical trial to ensure milestones are met and the study begins and ends per sponsor timelines, and general study maintenance including budget management during the life cycle of the study.
Amy is based in Wilmington, NC
Amy (Skydel) Pinette
Amy (Skydel) Pinette, Senior Consultant is a distinguished leader in the biotechnology and pharmaceutical industry, boasting over three decades of experience in clinical operations, program management, and cross-functional team leadership strategy and operations. Her career is marked by high-level executive roles within Biotech and CROs space with significant contributions to the advancement of neuroscience and gene therapy research and clinical trials.
Her experience includes multiple neuroscience indications including MS, ALS, Parkinson’s Disease, Alzheimer’s Disease, epilepsy, migraine, Duchenne Muscular Dystrophy, schizophrenia, bipolar disorder, and others. She has worked across different mechanisms of action and methods of administration from Phase I through large, global, Phase III trials. Her most recent gene therapy experience is working on such trials in ALS, Fabry Disease, and epilepsy beginning with IND preparation and submission through study start up for PhaseI/II trials in these indications. Amy began her career as a CRA at BMS and held positions of increasing responsiblity at UniQure, Parexel, InVentiv, and Premier Research (formerly SCIREX).
Amy holds a Bachelor of Science in Biology from McGill University and a master's degree in Neuroscience from the University of Hartford.
Amy’s strategic vision, dedication, and extensive expertise make her a driving force in the biotechnology and pharmaceutical industry, committed to bridging the gap between scientific discovery and patient care. Amy is based in Connecticut.